29.86MMarket Cap-3665P/E (TTM)
0.8724High0.8400Low43.99KVolume0.8400Open0.8351Pre Close37.58KTurnover0.25%Turnover RatioLossP/E (Static)35.42MShares3.250052wk High1.33P/B15.15MFloat Cap0.450052wk Low--Dividend TTM17.97MShs Float27.0500Historical High--Div YieldTTM3.88%Amplitude0.4500Historical Low0.8540Avg Price1Lot Size
Equillium Stock Forum
is this stock still even alive
$Equillium (EQ.US)$
Equillium Inc. (Nasdaq: EQ), a clinical-stage biotechnology company, recently announced promising topline results from its Phase 2 proof-of-concept (PoC) study of EQ101 in adult patients suffering from moderate, severe, or very-severe alopecia areata (AA). This autoimmune condition, driven by an immune cell attack on hair follicles, leads...
Equillium Announces Positive Topline Data From Phase 2 Study of EQ101 in Alopecia Areata
Equillium Inc: EQ101 Was Well Tolerated in Subjects With Alopecia Areata With No Serious Adverse Events Reported
No comment yet